
Sign up to save your podcasts
Or


Rachel Benton is a loving mother to an adorable 2-year-old boy named Stetson. Stetson doesn’t know it, but he may have already saved his mom’s life. A routine medical checkup, that Rachel only had because she was pregnant, showed protein in her urine. That discovery led to a biopsy and ultimately a diagnosis of IgA nephropathy – a serious kidney disease.
With patients like Rachel in mind, the research team at Vertex Pharmaceuticals is working on new approaches to address IgA nephropathy.
Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
-----------------------
Featured guests:
Rachel Benton is a young mother who lives with IgA nephropathy.
Dr. Jonathan Barratt leads the Renal Research Group within the College of Life Sciences, University of Leicester.
Mark Bunnage is Senior Vice President and Head of Global Research at Vertex Pharmaceuticals.
Dr Manish Maski is a board-certified nephrologist and helps lead Vertex’s research into IgA nephropathy in Boston.
Read more about Vertex's commitment to targeting kidney disease
By Vertex Pharmaceuticals4.9
3535 ratings
Rachel Benton is a loving mother to an adorable 2-year-old boy named Stetson. Stetson doesn’t know it, but he may have already saved his mom’s life. A routine medical checkup, that Rachel only had because she was pregnant, showed protein in her urine. That discovery led to a biopsy and ultimately a diagnosis of IgA nephropathy – a serious kidney disease.
With patients like Rachel in mind, the research team at Vertex Pharmaceuticals is working on new approaches to address IgA nephropathy.
Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
-----------------------
Featured guests:
Rachel Benton is a young mother who lives with IgA nephropathy.
Dr. Jonathan Barratt leads the Renal Research Group within the College of Life Sciences, University of Leicester.
Mark Bunnage is Senior Vice President and Head of Global Research at Vertex Pharmaceuticals.
Dr Manish Maski is a board-certified nephrologist and helps lead Vertex’s research into IgA nephropathy in Boston.
Read more about Vertex's commitment to targeting kidney disease

32,044 Listeners

30,719 Listeners

435 Listeners

1,383 Listeners

112,920 Listeners

9,530 Listeners

323 Listeners

8,809 Listeners

5,566 Listeners

9,888 Listeners

34 Listeners

2,079 Listeners

16,062 Listeners

19 Listeners

317 Listeners